$14.5 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 122 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 55.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOOG | Buy | ALPHABET INCcap stk cl c | $532,920,000 | +70.5% | 362,629 | +64.0% | 3.69% | +47.4% |
| IMMU | New | IMMUNOMEDICS INC | $498,276,000 | – | 5,860,000 | +100.0% | 3.45% | – |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $483,720,000 | +24.8% | 1,095,578 | +2.4% | 3.35% | +7.9% |
| TMUS | Buy | T-MOBILE US INC | $415,925,000 | +15.5% | 3,636,981 | +5.2% | 2.88% | -0.2% |
| CNC | Buy | CENTENE CORP DEL | $411,227,000 | -7.6% | 7,050,000 | +0.7% | 2.84% | -20.1% |
| FB | Buy | FACEBOOK INCcl a | $403,862,000 | +30.9% | 1,542,045 | +13.5% | 2.79% | +13.2% |
| ABBV | Buy | ABBVIE INC | $372,258,000 | -8.6% | 4,250,000 | +2.4% | 2.58% | -21.0% |
| AON | Buy | AON PLC | $362,334,000 | +9.3% | 1,756,344 | +2.1% | 2.51% | -5.5% |
| ANTM | Buy | ANTHEM INC | $342,452,000 | +4.2% | 1,275,000 | +2.0% | 2.37% | -10.0% |
| WAB | Buy | WABTEC | $336,599,000 | +35.2% | 5,439,551 | +25.8% | 2.33% | +16.8% |
| MSFT | Buy | MICROSOFT CORP | $324,114,000 | +4.2% | 1,540,978 | +0.8% | 2.24% | -9.9% |
| EMB | New | ISHARES TRput | $320,361,000 | – | 288,900 | +100.0% | 2.22% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $316,223,000 | – | 8,275,919 | +100.0% | 2.19% | – |
| NYT | Buy | NEW YORK TIMES COcl a | $304,068,000 | +74.9% | 7,106,042 | +71.7% | 2.10% | +51.1% |
| XLRN | Buy | ACCELERON PHARMA INC | $292,578,000 | +46.2% | 2,600,000 | +23.8% | 2.02% | +26.4% |
| TIF | Buy | TIFFANY & CO NEW | $264,949,000 | +42.2% | 2,287,000 | +49.7% | 1.83% | +22.9% |
| EXEL | Buy | EXELIXIS INC | $262,838,000 | +8.0% | 10,750,000 | +4.9% | 1.82% | -6.7% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $226,088,000 | +6.1% | 3,750,000 | +3.4% | 1.56% | -8.3% |
| PANW | Buy | PALO ALTO NETWORKS INC | $217,312,000 | +11.0% | 887,892 | +4.2% | 1.50% | -4.0% |
| EDU | Buy | NEW ORIENTAL ED & TECHNOLOGYspon adr | $204,632,000 | +149.0% | 1,368,778 | +116.9% | 1.42% | +115.0% |
| BX | Buy | BLACKSTONE GROUP INC | $199,891,000 | +27.4% | 3,829,336 | +38.3% | 1.38% | +10.2% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $192,900,000 | +14.4% | 1,250,000 | +9.6% | 1.33% | -1.1% |
| GD | Buy | GENERAL DYNAMICS CORP | $176,790,000 | +2.7% | 1,277,107 | +10.9% | 1.22% | -11.2% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $174,720,000 | +12.3% | 1,200,000 | +14.3% | 1.21% | -2.9% |
| MYOK | Buy | MYOKARDIA INC | $167,004,000 | +97.5% | 1,225,000 | +40.0% | 1.16% | +70.6% |
| WMGI | Buy | WRIGHT MED GROUP N V | $155,679,000 | +27.8% | 5,097,546 | +24.3% | 1.08% | +10.5% |
| TRU | Buy | TRANSUNION | $152,623,000 | +47.0% | 1,814,132 | +52.1% | 1.06% | +27.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $145,294,000 | +95.8% | 875,000 | +34.6% | 1.00% | +69.2% |
| HLT | New | HILTON WORLDWIDE HLDGS INC | $131,894,000 | – | 1,545,877 | +100.0% | 0.91% | – |
| HWM | Buy | HOWMET AEROSPACE INC | $120,558,000 | +534.3% | 7,210,388 | +501.3% | 0.83% | +448.7% |
| LVGO | New | LIVONGO HEALTH INC | $116,242,000 | – | 830,000 | +100.0% | 0.80% | – |
| CI | Buy | CIGNA CORP NEW | $85,083,000 | -9.3% | 502,231 | +0.4% | 0.59% | -21.6% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $84,258,000 | +0.1% | 600,000 | +14.3% | 0.58% | -13.5% |
| MXIM | New | MAXIM INTEGRATED PRODS INC | $83,160,000 | – | 1,230,000 | +100.0% | 0.58% | – |
| Buy | MOMO INCnote 1.250% 7/0 | $82,594,000 | +28.7% | 104,077,000 | +27.5% | 0.57% | +11.1% | |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $81,260,000 | -7.5% | 1,775,000 | +1.4% | 0.56% | -20.1% |
| NVCR | New | NOVOCURE LTD | $80,700,000 | – | 725,000 | +100.0% | 0.56% | – |
| FGEN | Buy | FIBROGEN INC | $76,072,000 | +15.5% | 1,850,000 | +13.8% | 0.53% | -0.2% |
| KSU | New | KANSAS CITY SOUTHERN | $71,247,000 | – | 394,000 | +100.0% | 0.49% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $68,637,000 | -6.6% | 2,275,000 | +1.1% | 0.48% | -19.2% |
| PCG | New | PG&E CORP | $68,472,000 | – | 7,292,042 | +100.0% | 0.47% | – |
| GBIO | Buy | GENERATION BIO CO | $65,549,000 | +47.3% | 2,120,625 | +0.1% | 0.45% | +27.2% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $64,176,000 | +81.6% | 1,050,000 | +23.5% | 0.44% | +56.9% |
| EFX | Buy | EQUIFAX INC | $62,208,000 | +41.7% | 396,484 | +55.3% | 0.43% | +22.5% |
| Buy | IQIYI INCnote 2.000% 4/0 | $59,119,000 | -3.8% | 61,762,000 | +0.5% | 0.41% | -16.9% | |
| GRFS | Buy | GRIFOLS S Asp adr rep b nvt | $54,284,000 | -4.4% | 3,128,750 | +0.5% | 0.38% | -17.4% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $54,124,000 | -15.6% | 700,000 | +21.7% | 0.37% | -27.1% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $53,763,000 | +21.8% | 2,750,000 | +10.0% | 0.37% | +5.4% |
| Buy | THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $49,808,000 | +21.9% | 56,695,000 | +35.3% | 0.34% | +5.5% | |
| Buy | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $46,694,000 | -7.1% | 38,523,000 | +9.7% | 0.32% | -19.7% | |
| CYTK | Buy | CYTOKINETICS INC | $46,548,000 | +31.7% | 2,150,000 | +43.3% | 0.32% | +13.8% |
| AMRS | Buy | AMYRIS INC | $40,880,000 | +36.6% | 14,000,000 | +99.7% | 0.28% | +17.9% |
| ZGNX | Buy | ZOGENIX INC | $40,343,000 | -25.3% | 2,250,000 | +12.5% | 0.28% | -35.4% |
| ANNX | New | ANNEXON INC | $40,392,000 | – | 1,657,261 | +100.0% | 0.28% | – |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $40,109,000 | +287.5% | 4,063,770 | +35.5% | 0.28% | +233.7% |
| ZYME | Buy | ZYMEWORKS INC | $39,695,000 | +100.1% | 852,200 | +54.9% | 0.28% | +73.0% |
| Buy | CLOVIS ONCOLOGY INCnote 1.250% 5/0 | $36,272,000 | +16.3% | 51,910,000 | +0.5% | 0.25% | +0.4% | |
| LNTH | Buy | LANTHEUS HLDGS INC | $33,576,000 | -10.9% | 2,650,000 | +0.6% | 0.23% | -23.2% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $33,084,000 | – | 600,000 | +100.0% | 0.23% | – |
| Buy | IQIYI INCnote 3.750%12/0 | $32,285,000 | -2.5% | 29,689,000 | +0.6% | 0.22% | -15.8% | |
| RDUS | Buy | RADIUS HEALTH INC | $23,898,000 | -16.5% | 2,107,400 | +0.4% | 0.16% | -27.9% |
| CLGX | New | CORELOGIC INC | $23,346,000 | – | 345,000 | +100.0% | 0.16% | – |
| BEKE | New | KE HLDGS INCsponsored ads | $20,536,000 | – | 335,000 | +100.0% | 0.14% | – |
| KRYS | Buy | KRYSTAL BIOTECH INC | $20,449,000 | +9.7% | 475,000 | +5.6% | 0.14% | -5.4% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $20,076,000 | -19.8% | 2,515,762 | +0.6% | 0.14% | -30.5% |
| ZEAL | Buy | ZEALAND PHARMA A/Ssponsored adr | $19,190,000 | +9.7% | 505,000 | +1.0% | 0.13% | -5.0% |
| QURE | Buy | UNIQURE NV | $16,574,000 | +22.6% | 450,000 | +50.0% | 0.12% | +6.5% |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $15,450,000 | – | 1,500,000 | +100.0% | 0.11% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $14,730,000 | – | 1,000,000 | +100.0% | 0.10% | – |
| Buy | DERMTECH INC | $14,579,000 | +466.0% | 1,219,999 | +526.7% | 0.10% | +381.0% | |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $12,667,000 | – | 362,940 | +100.0% | 0.09% | – |
| NAV | New | NAVISTAR INTL CORP NEW | $12,043,000 | – | 276,600 | +100.0% | 0.08% | – |
| New | ATENTO S A | $11,998,000 | – | 2,230,357 | +100.0% | 0.08% | – | |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $11,652,000 | – | 150,000 | +100.0% | 0.08% | – |
| WLTW | New | WILLIS TOWERS WATSON PLC LTD | $10,441,000 | – | 50,000 | +100.0% | 0.07% | – |
| LQDA | Buy | LIQUIDIA TECHNOLOGIES INC | $9,178,000 | -41.1% | 1,865,350 | +0.8% | 0.06% | -49.6% |
| INBX | New | INHIBRX INC | $7,110,000 | – | 395,000 | +100.0% | 0.05% | – |
| TARA | New | PROTARA THERAPEUTICS INC | $7,153,000 | – | 425,000 | +100.0% | 0.05% | – |
| ALBO | New | ALBIREO PHARMA INC | $6,674,000 | – | 200,000 | +100.0% | 0.05% | – |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $6,516,000 | – | 741,290 | +100.0% | 0.04% | – |
| IVA | New | INVENTIVA SAads | $6,229,000 | – | 527,870 | +100.0% | 0.04% | – |
| Buy | RADIUS HEALTH INCnote 3.000% 9/0 | $5,474,000 | +9.3% | 6,783,000 | +0.5% | 0.04% | -5.0% | |
| ARYBU | Buy | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $4,428,000 | -4.6% | 402,523 | +0.6% | 0.03% | -16.2% |
| ISEE | Buy | IVERIC BIO INC | $4,257,000 | +11.3% | 754,740 | +0.6% | 0.03% | -6.5% |
| ACIA | New | ACACIA COMMUNICATIONS INC | $4,044,000 | – | 60,000 | +100.0% | 0.03% | – |
| EQ | New | EQUILLIUM INC | $4,039,000 | – | 700,000 | +100.0% | 0.03% | – |
| DYN | New | DYNE THERAPEUTICS INC | $4,038,000 | – | 200,000 | +100.0% | 0.03% | – |
| New | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $3,830,000 | – | 3,522,000 | +100.0% | 0.03% | – | |
| QTNT | New | QUOTIENT LTD | $3,213,000 | – | 625,000 | +100.0% | 0.02% | – |
| CRDF | New | CARDIFF ONCOLOGY INC | $2,838,000 | – | 200,000 | +100.0% | 0.02% | – |
| AMWL | New | AMERICAN WELL CORPcl a | $1,334,000 | – | 45,000 | +100.0% | 0.01% | – |
| PAND | New | PANDION THERAPEUTICS INC | $1,146,000 | – | 100,000 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.